Drug Profile
BMP 655
Alternative Names: BMP655; PF-05208762; PF5208762Latest Information Update: 18 Aug 2011
Price :
$50
*
At a glance
- Originator Wyeth
- Developer Pfizer
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Tendon injuries
Most Recent Events
- 11 Aug 2011 Discontinued - Phase-I for Tendon injuries in Japan (Implant)
- 11 Aug 2011 Discontinued - Phase-I for Tendon injuries in Netherlands (Implant)
- 15 Oct 2009 Wyeth has been acquired by Pfizer